Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022

人工心臓弁の世界市場予測(~2022年):経カテーテル心臓弁、組織心臓弁、機械式心臓弁

◆タイトル:Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022
◆商品コード:MAM-MD4094
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年6月5日
◆ページ数:159
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、人工心臓弁の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、地域別分析、人工心臓弁の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Prosthetic Heart Valves Market Projected to Grow at a CAGR of 12.9% in the Forecast Period (2017 to 2022)”The prosthetic heart valves market is projected to reach USD 8.86 billion by 2022, at a CAGR of 12.9% from 2017 to 2022. The major factors driving the growth of this market include the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves.

“Transcatheter Heart Valves to Register the Highest CAGR During the Forecast Period”
Based on the type of valve, the prosthetic heart valves market is categorized as transcatheter heart valves, tissue heart valves, and mechanical heart valves. The transcatheter heart valves segment is expected to register the highest CAGR during the forecasting period. Factors such as the rising prevalence of aortic stenosis, increasing pool of patients owing to approvals for extended valve indications, and technological advancements are supporting the growth of this segment.

“North America Is Estimated to Be the Fastest-growing Regional Segment in the Global Prosthetic Heart Valves Market During the Forecast Period”
In 2017, North America is expected to dominate the prosthetic heart valves market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). This regional segment is also projected to register the highest CAGR during the forecast period. Factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to the growth of the North American prosthetic heart valves market.

The primary interviews conducted for this report can be categorized as follows:
 By Company Type: Tier 1: 52%, Tier 2: 30%, Tier 3: 18%
 By Designation: Director-level: 43%, C-level: 36%, Others: 21%
 By Region: North America: 43%, Europe: 23%, APAC: 20%, RoW: 14%

The key players in this market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil).

Research Coverage:
The report analyses the prosthetic heart valves market by type of valve and region. Apart from comprehensive geographic analysis, market sizing and volume analysis, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles section in the report comprises the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

Key Benefits of Buying the Report:
The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) to strengthen their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the products offered by the top players in the prosthetic heart valves market. The report analyzes the prosthetic heart valves market by type of valve
• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the prosthetic heart valves market
• Market Development: Comprehensive information about lucrative emerging markets.
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the prosthetic heart valves market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the prosthetic heart valves market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH METHODOLOGY STEPS 19
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 20
2.2.1 SECONDARY RESEARCH 20
2.2.2 PRIMARY RESEARCH 21
2.2.2.1 Key industry insights 22
2.2.2.2 Key data from primary sources 23
2.2.2.3 Key insights from primary sources 24
2.3 MARKET SIZE ESTIMATION METHODOLOGY 25
2.4 RESEARCH DESIGN 29
2.5 MARKET DATA VALIDATION AND TRIANGULATION 30
2.6 ASSUMPTIONS FOR THE STUDY 31

3 EXECUTIVE SUMMARY 32

4 PREMIUM INSIGHTS 35
4.1 INTRODUCTION 35
4.2 GLOBAL PROSTHETIC HEART VALVES MARKET, BY TYPE OF VALVE, 2017 VS. 2022 36
4.3 GEOGRAPHICAL SNAPSHOT OF GLOBAL PROSTHETIC HEART VALVES MARKET 37

5 MARKET OVERVIEW 38
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
5.2.1 DRIVERS 40
5.2.1.1 Rising geriatric population and subsequent growth in prevalence of heart valve disease 40
5.2.1.2 Regulatory approvals for new and advanced prosthetic heart valves 41
5.2.1.2.1 Product approvals for Medtronic plc: 41
5.2.1.2.2 Product approvals for Edward Lifesciences Corporation: 41
5.2.1.2.3 Product approvals for Boston Scientific Corporation: 41
5.2.1.2.4 Product approvals for Livanova PLC: 42
5.2.1.2.5 Product approvals for St. Jude Medical, Inc.: 42
5.2.1.2.6 Product approvals for other companies: 42
5.2.1.3 Increasing government funding for heart valve research 43
5.2.1.4 Rising awareness about heart valve diseases 43
5.2.1.5 Favorable reimbursement scenario for prosthetic heart valves 44
5.2.2 RESTRAINTS 45
5.2.2.1 High cost of transcatheter aortic valve replacement (TAVR) procedures 45
5.2.2.2 Availability of alternative methods for treating heart valve diseases (HVD) 45
5.2.3 OPPORTUNITIES 46
5.2.3.1 Expanding indication of TAVR from only high-risk to intermediate- or low-risk patients 46
5.2.3.2 Strong product pipeline 46
5.2.3.3 Increasing investments by key players in startup companies 47
5.2.3.4 Growth potential offered by emerging countries 48
5.2.4 CHALLENGE 49
5.2.4.1 Emergence of tissue-engineered heart valves (TEHV) 49

6 GLOBAL PROSTHETIC HEART VALVE MARKET, BY TYPE OF VALVE 50
6.1 INTRODUCTION 51
6.2 TRANSCATHETER HEART VALVES 53
6.3 TISSUE HEART VALVES 57
6.4 MECHANICAL HEART VALVES 61

7 GLOBAL PROSTHETIC HEART VALVE MARKET, BY REGION 65
7.1 INTRODUCTION 66
7.2 NORTH AMERICA 67
7.2.1 U.S. 69
7.2.1.1 Rapid growth in the aging population and prevalence of valvular heart diseases 69
7.2.1.2 Rising preference for transcatheter aortic valve replacement (TAVR) 69
7.2.1.3 Favorable reimbursement scenario for prosthetic heart valves 70
7.2.1.4 Initiatives to increase awareness of valvular heart diseases (VHD) 70
7.2.1.5 Stringent regulations for new prosthetic heart valve approval 70
7.2.2 CANADA 71
7.2.2.1 Favorable reimbursement and funding 71
7.2.2.2 Rising approvals for heart valves 72

7.3 EUROPE 73
7.3.1 INCREASING AGING POPULATION AND VALVULAR HEART DISEASES (VHD) PREVALENCE 74
7.3.2 GROWTH IN THE NUMBER OF RESEARCH ACTIVITIES 74
7.3.3 GERMANY 76
7.3.3.1 Favorable reimbursement policies 76
7.3.4 FRANCE 77
7.3.4.1 Valve for life (VFL) initiative 77
7.3.5 U.K. 78
7.3.5.1 Establishment of specialty valve clinics 78
7.3.6 REST OF EUROPE (ROE) 79
7.3.6.1 Rising initiatives and awareness programs in Poland and Portugal 79
7.4 ASIA-PACIFIC 81
7.4.1 JAPAN 83
7.4.1.1 Rising aging population 83
7.4.1.2 Favorable reimbursement scenario 83
7.4.1.3 Dilution of regulatory stringency 84
7.4.2 CHINA 85
7.4.2.1 Rising aging population and prevalence of valvular heart diseases in china 85
7.4.2.2 Unfavorable reimbursements 85
7.4.3 INDIA 86
7.4.3.1 High patient pool for target diseases 86
7.4.3.2 State government funded insurance schemes 87
7.4.4 REST OF ASIA-PACIFIC (ROAPAC) 88
7.4.4.1 Growing medical tourism in Asian countries 88
7.5 REST OF THE WORLD 89
7.5.1 RISE IN AGING POPULATION 90
7.5.2 HIGH PREVALENCE OF HEART VALVE DISEASE IN BRAZIL 90
7.5.3 FAVORABLE MEDICAL TOURISM DESTINATION 90

8 COMPETITIVE LANDSCAPE 92
8.1 MARKET SHARE ANALYSIS (2016) 92
8.1.1 INTRODUCTION 92
8.1.2 GLOBAL TRANSCATHETER HEART VALVES MARKET SHARE, BY KEY PLAYER, 2016 92
8.1.3 GLOBAL TISSUE HEART VALVES MARKET SHARE, BY KEY PLAYER, 2016 93
8.1.4 GLOBAL MECHANICAL HEART VALVES MARKET SHARE, BY KEY PLAYER, 2016 93
8.1.5 EDWARDS LIFESCIENCES CORPORATION 94
8.1.6 MEDTRONIC PLC 95
8.1.7 ST. JUDE MEDICAL, INC. 96

8.2 VENDOR DIVE OVERVIEW 96
8.2.1 VANGUARDS 96
8.2.2 INNOVATOR 96
8.2.3 DYNAMIC 97
8.2.4 EMERGING 97
8.3 COMPETITIVE BENCHMARKING 98
8.3.1 ANALYSIS OF PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE PROSTHETIC HEART VALVE MARKET (18 PLAYERS) 98
8.3.2 BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE PROSTHETIC HEART VALVE MARKET (18 PLAYERS) 99
*Top 13 companies analysed for this study are – Edwards Lifesciences Corporation (U.S.), Medtronic plc (Ireland), St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.), Boston Scientific Corporation (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), JenaValve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil). Other players in this market include Micro Interventional Devices, Inc. (U.S.), Autotissue Berlin GmbH (Germany), Comed B.V. (Netherlands), Meril Life Sciences Pvt. Ltd. (India), Labcor Laboratórios Ltda. (Brazil), and HLT Inc. (A Bracco Group Company) (U.S.)

9 COMPANY PROFILES 100
(Overview, Products and Services, Financials, Strategy & Development)*

9.1 INTRODUCTION 100
9.2 MEDTRONIC PLC 101
9.3 EDWARDS LIFESCIENCES CORPORATION 106
9.4 BOSTON SCIENTIFIC CORPORATION 111
9.5 LIVANOVA PLC 117
9.6 ST. JUDE MEDICAL, INC. (AN ABBOTT LABORATORIES COMPANY) 122
9.7 SYMETIS SA 125
9.8 JENAVALVE TECHNOLOGY, INC. 128
9.9 CRYOLIFE, INC. 131
9.10 TTK HEALTHCARE LIMITED (A TTK GROUP COMPANY) 135
9.11 COLIBRI HEART VALVE, LLC 138
9.12 LEPU MEDICAL TECHNOLOGY CO., LTD. 141
9.13 BRAILE BIOMÉDICA 144
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

10 APPENDIX 147
10.1 DISCUSSION GUIDE 147
10.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 151
10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 153
10.4 AVAILABLE CUSTOMIZATIONS 154
10.5 RELATED REPORTS 155
10.6 AUTHOR DETAILS 156

LIST OF TABLES

TABLE 1 GLOBAL PROSTHETIC HEART VALVES MARKET SNAPSHOT 32
TABLE 2 GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE OF VALVE,
2015–2022 (USD MILLION) 52
TABLE 3 GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE OF VALVE,
2015–2022 (UNITS) 52
TABLE 4 GLOBAL TRANSCATHETER HEART VALVES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 54
TABLE 5 GLOBAL TRANSCATHETER HEART VALVES MARKET SIZE, BY REGION,
2015–2022 (UNITS) 54
TABLE 6 NORTH AMERICA: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 55
TABLE 7 NORTH AMERICA: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2015–2022 (UNITS) 55
TABLE 8 EUROPE: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 55
TABLE 9 EUROPE: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (UNITS) 56
TABLE 10 ASIA-PACIFIC TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 56
TABLE 11 ASIA-PACIFIC: TRANSCATHETER HEART VALVES MARKET SIZE, BY COUNTRY, 2015–2022 (UNITS) 57
TABLE 12 GLOBAL TISSUE HEART VALVES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 58
TABLE 13 GLOBAL TISSUE HEART VALVES MARKET SIZE, BY REGION, 2015–2022 (UNITS) 58
TABLE 14 NORTH AMERICA: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 58
TABLE 15 NORTH AMERICA: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (UNITS) 59
TABLE 16 EUROPE: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 59
TABLE 17 EUROPE: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY, 2015–2022 (UNITS) 59
TABLE 18 ASIA-PACIFIC: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 60
TABLE 19 ASIA-PACIFIC: TISSUE HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (UNITS) 60
TABLE 20 GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 61
TABLE 21 GLOBAL MECHANICAL HEART VALVES MARKET SIZE, BY REGION,
2015–2022 (UNITS) 62
TABLE 22 NORTH AMERICA: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 62
TABLE 23 NORTH AMERICA: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY, 2015–2022 (UNITS) 62
TABLE 24 EUROPE: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 63
TABLE 25 EUROPE: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (UNITS) 63
TABLE 26 ASIA-PACIFIC: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 64
TABLE 27 ASIA-PACIFIC: MECHANICAL HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (UNITS) 64
TABLE 28 GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 66
TABLE 29 GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION,
2015–2022 (UNITS) 66
TABLE 30 NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 68
TABLE 31 NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (UNITS) 68
TABLE 32 NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 68
TABLE 33 NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (UNITS) 69
TABLE 34 MEDICARE NATIONAL AVERAGE COVERAGE FOR HEART VALVE REPLACEMENT PROCEDURES 70
TABLE 35 U.S.: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 71
TABLE 36 U.S.: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 71
TABLE 37 CANADA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 72
TABLE 38 CANADA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 72
TABLE 39 EUROPE: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 75
TABLE 40 EUROPE: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (UNITS) 75
TABLE 41 EUROPE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 75
TABLE 42 EUROPE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (UNITS) 76
TABLE 43 GERMANY: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 76
TABLE 44 GERMANY: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (UNITS) 77
TABLE 45 FRANCE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 77
TABLE 46 FRANCE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 78
TABLE 47 U.K.: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 78
TABLE 48 U.K.: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 79
TABLE 49 ROE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 80
TABLE 50 ROE: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 80
TABLE 51 ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 82
TABLE 52 ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY,
2015–2022 (UNITS) 82
TABLE 53 ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 83
TABLE 54 ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (UNITS) 83
TABLE 55 JAPAN: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 84
TABLE 56 JAPAN: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 85
TABLE 57 CHINA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 86
TABLE 58 CHINA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 86
TABLE 59 INDIA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 87
TABLE 60 INDIA: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 87
TABLE 61 ROAPAC: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 88
TABLE 62 ROAPAC: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 88
TABLE 63 ROW: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 91
TABLE 64 ROW: PROSTHETIC HEART VALVES MARKET SIZE, BY TYPE, 2015–2022 (UNITS) 91


LIST OF FIGURES

FIGURE 1 GLOBAL PROSTHETIC HEART VALVES MARKET SEGMENTATION 16
FIGURE 2 GLOBAL PROSTHETIC HEART VALVES MARKET: RESEARCH METHODOLOGY STEPS 19
FIGURE 3 KEY DATA FROM SECONDARY SOURCES 20
FIGURE 4 PRIMARY RESEARCH - CURRENT SAMPLING FRAME 22
FIGURE 5 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 23
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL MARKET 25
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR THE TRANSCATHETER HEART VALVES MARKET 26
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR THE TISSUE HEART VALVES MARKET 26
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR THE MECHANICAL HEART VALVES MARKET 27
FIGURE 10 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR THE GLOBAL PROSTHETIC HEART VALVES MARKET 27
FIGURE 11 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 28
FIGURE 12 DATA TRIANGULATION METHODOLOGY 30
FIGURE 13 TRANSCATHETER HEART VALVES SEGMENT TO REGISTER THE HIGHEST CAGR FROM 2017 TO 2022 33
FIGURE 14 NORTH AMERICA TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD 34
FIGURE 15 EVOLUTION OF PROSTHETIC HEART VALVES 35
FIGURE 16 RISING PREVALENCE OF HEART VALVE DISEASE IS ONE OF THE MAJOR FACTORS DRIVING THE GROWTH OF THE PROSTHETIC HEART VALVES MARKET 35
FIGURE 17 TRANSCATHETER HEART VALVES TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 36
FIGURE 18 NORTH AMERICA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 37
FIGURE 19 GLOBAL PROSTHETIC HEART VALVES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE 39
FIGURE 20 GLOBAL PROSTHETIC HEART VALVES MARKET, BY TYPE OF VALVE 51
FIGURE 21 TRANSCATHETER HEART VALVES SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 53
FIGURE 22 NORTH AMERICA: PROSTHETIC HEART VALVES MARKET SNAPSHOT 67
FIGURE 23 EUROPE: PROSTHETIC HEART VALVES MARKET SNAPSHOT 73
FIGURE 24 ASIA-PACIFIC: PROSTHETIC HEART VALVES MARKET SNAPSHOT 81
FIGURE 25 ROW: PROSTHETIC HEART VALVES MARKET SNAPSHOT 89
FIGURE 26 VENDOR DIVE COMPARISON MATRIX: PROSTHETIC HEART VALVES MARKET 97
FIGURE 27 PRODUCT MIX OF KEY PLAYERS IN MARKET 100
FIGURE 28 MEDTRONIC PLC: COMPANY SNAPSHOT (2015) 101
FIGURE 29 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2016) 106
FIGURE 30 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016) 112
FIGURE 31 NEOVASC INC.: COMPANY SNAPSHOT (2016) 113
FIGURE 32 LIVANOVA PLC: COMPANY SNAPSHOT (2016) 118
FIGURE 33 ST. JUDE MEDICAL, INC. (AN ABBOTT LABORATORIES COMPANY):
COMPANY SNAPSHOT (2015) 122
FIGURE 34 CRYOLIFE, INC.: COMPANY SNAPSHOT (2016) 131
FIGURE 35 TTK HEALTHCARE LIMITED: COMPANY SNAPSHOT (2015) 135


【レポートのキーワード】

人工弁、人工心臓弁、経カテーテル心臓弁、組織心臓弁、機械式心臓弁、医療機器

★調査レポート[人工心臓弁の世界市場予測(~2022年):経カテーテル心臓弁、組織心臓弁、機械式心臓弁] ( Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022 / MAM-MD4094) 販売に関する免責事項
[人工心臓弁の世界市場予測(~2022年):経カテーテル心臓弁、組織心臓弁、機械式心臓弁] ( Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022 / MAM-MD4094) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆